Effect of CPT-11 on lipid peroxide level in mouse tissues

Japanese Journal of Cancer Research

Volumn 88, Issue 5, 1997, Pages 512-516

  Sadzuka, Yasuyuki ^a   Hirota, Sadao ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Antitumor agent; CPT 11; Glutathione peroxidase; Lipid peroxide; Side effect

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTATHIONE PEROXIDASE; IRINOTECAN; LIPID PEROXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CARDIOTOXICITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; LIVER MICROSOME; LUNG; LUNG TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE LEVEL;

EID: 0030983235     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00411.x     Document Type: Article

References (26)

1. Sawada, S., Okajima, S., Aiyama, R., Nokota, K., Furuta, T., Yokokura, T., Sugini, E., Yamaguchi, K. and Miyasaka, K. Synthesis and antitumor activity of 20(S)-camptothecin derivatives. Carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydrocamptothecin. Chem. Pharm. Bull., 39, 1446-1454 (1991).
2. Taguchi, T., Wakui, A., Hasegawa, K., Niitani, H., Furue, H., Ohta, K. and Hattori, T. Phase I clinical study of CPT-11. Research group of CPT-11. Jpn. J. Cancer Res., 17, 115-120 (1990).
3. Kawato, Y., Furuta, T., Aonuma, M., Yasuoka, M., Yokokura, T. and Matsumoto, K. Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice. Cancer Chemother. Pharmacol., 28, 192-198 (1991).
4. Potmesil, M. Camptothecins: from bench research to hospital wards. Cancer Res., 54, 1431-1439 (1994).
5. Liu, L. F. DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem., 58, 351-375 (1989).
6. Nishimura, G., Satou, T., Yoshimitsu, Y., Kurasaka, Y., Fujimura, T., Sugiyama, K., Kanno, M., Yonemura, Y., Miwa, K. and Miyazaki, I. Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer. Jpn. J. Cancer Chemother., 22, 93-97 (1995).
7. Goto, Y. Lipid peroxide and arteriosclerosis. SaishinIgaku, 33, 691-695 (1978) (in Japanese).
8. Abe, H., Suematsu, T., Kamata, T., Sato, N. and Matsunuma, T. Clinical significance of lipoperoxides in liver diseases. Saishin-Igaku, 33, 708-714 (1978) (in Japanese).
9. Uehara, S. and Hirayama, A. Lipid peroxide levels in several diseases. Jpn. J. Clin. Pathol., 29, 250-255 (1981).
10. Yagi, K. Vascular disorders and active oxygen. Metabolism, 25, 815-821 (1988).
11. Sadzuka, Y., Shoji, T. and Takino, Y. Change of lipid peroxide levels in rat tissues after cisplatin administration. ToxicoL Lett., 57, 159-166 (1991).
12. Bus, J. S., Cagen, C. Z., Olgano, M. and Gibso, J. E. A mechanism of paraquat toxicity in mice and rats. Toxicol. Appl. Pharmacol., 35, 501-513 (1976).
13. Sadzuka, Y., Tanizawa, H. and Takino, Y. Change of lipid peroxide levels in mouse organs after adriamycin administration. Chem. Pharm. Bull., 31, 1714-1718 (1983).
14. Sazuka, Y., Tanizawa, H. and Takino, Y. Effect of adriamycin on the activities of Superoxide dismutase, glutathione peroxidase and catalase in tissues of mice. Jpn. J. Cancer Res., 80, 89-94 (1989).
15. Sazuka, Y., Tanizawa, H. and Takino, Y. Effect of adriamycin on DNA, RNA and protein biosyntheses in mouse tissues, in connection with its cardiotoxicity. Jpn. J. Cancer Res., 80, 1000-1005 (1989).
16. Myers, C. E., McGuire, W. P. and Young, R. C. Adriamycin: amelioration of toxicity by α-tocopherol. Cancer Treat. Rep., 60, 961-962 (1976).
17. Myers, C. E., McGuire, W. P., Liss, R. H., Ifrim, I., Grotzinger, K. and Young, R. C. Adriamycin: the rule of lipid peroxidation in cardiac toxicity and tumor response. Science, 197, 165-167 (1977).
18. Yamanaka, N. "Lipid Peroxide and Disease," ed. K. Yagi and Y. Goto, pp. 225-231 (1981). Igaku Shoin, Tokyo (in Japanese).
19. Sadzuka, Y., Tanizawa, H. and Takino, Y. Microdetermination of lipoperoxide level in the mouse myocardium by thiobarbituric acid fluorophotometry. Chem. Pharm. Bull., 29, 2910-2914 (1981).
20. Hafeman, D. G., Sunde, R. A. and Hoekstra, W. G. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nutr., 104, 580-587 (1974).
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
22. Svingen, B. A., Bus, J. A., O'Neal, F. O. and Aust, S. D. The mechanism of NADPH-dependent lipid peroxidation. J. Biol. Chem., 254, 5892-5899 (1979).
23. Ono, Y., Aihara, K., Iwasaki, T., Yoshida, K., Sagara, N., Sekiguchi, M. and Onodera, I. Acute toxicity study of CPT-11 in mice, rats and dog. Clin. Rep., 24, 7185-7195 (1990).
24. Sadzuka, Y. and Takino, Y. Effect of tetrahydropyranyl-adriamycin (THP-ADR) and 4′-epiadriamycin (4′-epi-ADR) on lipid peroxide levels in mice. Chem. Pharm. Bull., 40, 1329-1331 (1992).
25. Fischer, D. S., Knobf, M. T. and Durivage, H. J. "The Cancer Chemotherapy Handbook," 4th Ed., p.82 (1993). Mosby-Year Book, Inc., St. Louis.
26. Sasaki, Y., Hakusui, H., Mizuno, S., Morita, M., Miya, T., Eguchi, K., Shinkai, T., Ohe, Y. and Saijo, N. A pharmacokinetic and pharmacodynamic analysis of CPT-11 and its active metabolite SN-38. Jpn. J. Cancer Res., 86, 101-110 (1995).